Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-64
SponsorAjou University School of Medicine

About this trial

After surgery is completed under general anesthesia, extubation is performed after recovery from anesthesia, and during this process, bucking, coughing, and rapid and excessive hemodynamic fluctuations occur very often. These phenomena can lead to high intrathoracic pressure, venous congestion, hematoma formation, or increased bleeding after major neck surgery. (1) They can also increase the risk of aerosol generation, which can transmit infection to health care workers. (2) For this, smooth extubation is required. Methods of administering drugs such as lidocaine, opioids, or dexmedetomidine have been proposed for smooth extubation. (3-5) As a disadvantage, the use of these drugs may be associated with deep sedation and reduced airway reflexes .

Recently, Babu et al. (6) reported that bucking and coughing during extubation could be reduced by changing the timing of administering a muscle relaxant antagonist rather than using these sedative drugs, and thus complications related to extubation could be reduced. In general, in the awakening process, it was common to administer the muscle relaxant at the point of recovery of spontaneous breathing. However, Babu et al. demonstrated the possibility of safe and smooth extubation by changing the timing of administering neostigmine without the use of sedatives or narcotic analgesics, but there are few studies on sugammadex.

Therefore, when recovering from general anesthesia, sugammadex was administered before and immediately after extubation to evaluate and compare smooth extubation (ie, comparison of the frequency of bucking and coughing).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients undergoing general anesthesia for thyroid surgery.

aged between 19 and 64 years

American Society of Anesthesiologists physical status I and II

Disqualifiers

patients with malformation or tumor of the upper respiratory tract

patients with risk of aspiration

obese cases with a BMI > 35

patients in which tracheal intubation was difficult

Trial design

Design model

Parallel

Treatments tested in this trial

  • sugammadex

    Drug

    sugammadex is administered just after extubation

Treatment groups

66 Participants
are divided into 2 treatment groups
Group A: Control groupNo intervention 0 interventions
Group B: Experimental groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

extubation quality score

score based on the incidence and severity of coughing straining

Time frame
immediate after extubation

Secondary outcomes

1

time to respiration

time from withdrawal of anesthetics to respiration

Time frame
immediate after extubation
2

time to extubation

time from withdrawal of anesthetics to extubation

Time frame
immediate after extubation
3

sore throat in postanesthetic care unit

Scores obtained by questioning the patient in postanesthetic care unit

Time frame
in postanesthetic care unit

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: